Latest filing published 08 Aug 2019 for ReShape Lifesciences Inc., €892k. Read the official filing
Not enough history yet: 0 closed purchases, at least 2 are needed.
Parters Vii L. P. Domain is a declared insider at 3 companies; the most frequent names are Evoke Pharma Inc, ReShape Lifesciences Inc. and Tobira Therapeutics, Inc. Over a trading history stretching from 6 April 2016 to 6 August 2019, the count stands at 13 filings.
In open-market terms, that means 2 purchases worth €3.5M on one side and 9 sales worth €1.9M on the other. The net balance comes to €1.6M on the buying side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2019 alone, the filings show 1 purchase and no sales.
The newest entry dates from 8 August 2019: an open-market purchase of €892k, in ReShape Lifesciences Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations